S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Beam Therapeutics (BEAM) Insider Trading & Ownership

$24.31
-1.39 (-5.41%)
(As of 04/17/2024 ET)

Beam Therapeutics (NASDAQ:BEAM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$9.89 M
Get BEAM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Beam Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BEAM Insider Buying and Selling by Quarter

Beam Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2024Amy SimonInsiderSell7,157$32.13$229,954.41  
4/1/2024Giuseppe CiaramellaPresidentSell4,534$32.12$145,632.08  
4/1/2024John M EvansCEOSell18,102$32.13$581,617.26  
4/1/2024Terry-Ann BurrellCFOSell5,446$32.12$174,925.52  
3/28/2024John M EvansCEOSell60,000$33.86$2,031,600.00  
2/13/2024Fmr LlcInsiderSell1,565$30.76$48,139.40  
1/31/2024John M EvansCEOSell60,000$25.33$1,519,800.00  
1/3/2024Christine BellonInsiderSell1,907$26.42$50,382.94  
10/30/2023Amy SimonInsiderSell3,448$18.70$64,477.60  
10/2/2023Christine BellonInsiderSell388$22.85$8,865.80  
7/24/2023Giuseppe CiaramellaInsiderSell1,206$32.01$38,604.06  
7/21/2023Giuseppe CiaramellaInsiderSell155,324$32.06$4,979,687.44  
7/10/2023Amy SimonInsiderSell391$30.48$11,917.68  
(Data available from 1/1/2013 forward)

BEAM Insider Trading Activity - Frequently Asked Questions

Who is on Beam Therapeutics's Insider Roster?

The list of insiders at Beam Therapeutics includes Amy Simon, Christine Bellon, Fmr Llc, Giuseppe Ciaramella, Graham K Cooper, John M Evans, and Terry-Ann Burrell. Learn more on insiders at BEAM.

What percentage of Beam Therapeutics stock is owned by insiders?

4.40% of Beam Therapeutics stock is owned by insiders. Learn more on BEAM's insider holdings.

Which Beam Therapeutics insiders have been selling company stock?

The following insiders have sold BEAM shares in the last 24 months: Amy Simon ($306,349.69), Christine Bellon ($59,248.74), Fmr Llc ($1,277,862.40), Giuseppe Ciaramella ($7,400,398.66), John M Evans ($8,790,647.17), and Terry-Ann Burrell ($3,096,052.98).

How much insider selling is happening at Beam Therapeutics?

Insiders have sold a total of 553,449 Beam Therapeutics shares in the last 24 months for a total of $20,930,559.64 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:BEAM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners